Medical, Health, & Pharmacy News Headlines

Pharmacy News Archives

Medical News Today
EurekAlert!
Univ. of Maryland
Medbroadcast.com
Reuters Health/Medical
New York Times Health
BBC Health & Medical
PRWeb Pharmaceuticals

Popular Medications

Weight Loss & Diet
Pain Relief
Men's Health
Women's Health
Skin Care
Quit Smoking
Sexual Health
Muscle Relaxants
Allergy Relief
Anti-depressants
Anxiety
Sleep Aids
Gastro-intestinal

Insurance & Litigation

Viatical Settlement

Tools & Information

Currency Converter
Resource Directory
Pharmacy Affiliate

 Back to PRWeb Archives



PRWeb: 11-18-2004

Metastatic Prostate Cancer: New Studies Indicate Improvement with PC Hope
Two new studies indicate that for men with prostate cancer, PC Hope is associated with significant improvements in quality of life, reductions in patients’ pain rating, and a decline in PSA levels without major side effects. [PRWEB Nov 18, 2004]

Jack Shapiro - "If Government Can't Guarantee Safety of Imported Drugs, Why Do We Import So Much of Them?"
"Both the Clinton and Bush administrations have cautioned about the government's inability to guarantee the safety of imported pharmaceuticals, yet, the government allows importation of $50 billion per year of these products," notes Jack Shapiro, an internationally-known healthcare marketing consultant, futurist, broadcast journalist, and public speaker [PRWEB Nov 18, 2004]

Research And Markets The Inability To Accurately Predict Toxicity Early In Drug Development Cost The Pharmaceutical Industry $8 Billion In 2003, Approximately One-Third The Cost Of All Drug Failures
Research and Markets (researchandmarkets.com/reports/c9045) has announced the addition of Toxicogenomics and Predictive Toxicology: Market and Business Outlook to their offering. [PRWEB Nov 18, 2004]

Research And Markets - Nuclear Receptors: The Market For Nuclear Receptor Targeted Drugs Is Estimated To Be 10-15% Of The $400 Billion Global Pharmaceutical Market
Research and Markets (researchandmarkets.com/reports/c9248) has announced the addition of Nuclear Receptors: Key Targets for New Pharmaceuticals to their offering. [PRWEB Nov 18, 2004]

Research And Markets - Lack Of Necessary Research Resources Can Lead To The Failure Of Pharmaceutical Brand Teams To Complete Their Most Important Tasks
Research and Markets (researchandmarkets.com/reports/c9391) has announced the addition of Pharmaceutical Market Research: Decision Support for Brand Growth to their offering. [PRWEB Nov 18, 2004]

By 2008, the Pharmaceutical Customer Relationship Management Market Will Grow To Be Approximately $625M Worldwide
Research and Markets (researchandmarkets.com/reports/c9470) has announced the addition of Pharmaceutical Customer Relationship Management: Tools to Improve Sales Force Effectiveness & Productivity to their offering [PRWEB Nov 18, 2004]

Parkinson's Disease May Have Cure Around the Corner
William Hansen discovered a treatment for Parkinson’s disease that eliminates almost all symptoms after being diagnosed with the disease himself in 1997. The treatment is outlined in his book, “I’m Dancing Again Because HOPE HEALS”, and includes the oral vitamin sprays developed by and tested on Mr. Hansen himself, Parkimin™ Sprays. [PRWEB Nov 17, 2004]

Buying Medical Products Online Safely and Securely
Consumer protection against bogus pharmacies proliferating on the internet. How to identify a good place to buy your prescription medicines safely, securely, and effectively, overnight, under doctor supervision. [PRWEB Nov 17, 2004]

Research And Markets - View These Extensive Reviews Focused On Pharmacology, Pharmacokinetics, Toxicology, And Clinical Trials Of New Or Potential Cardiovascular Drugs
Research and Markets (researchandmarkets.com/reports/c9291) has announced the addition of Cardiovascular Drug Reviews to their offering. [PRWEB Nov 17, 2004]

Research and Markets - Lack of Genuine Innovation and Lack of Commitment to Refining Existing R&D Processes Continue to Inhibit Growth in Pharmaceutical Industry
Research and Markets (researchandmarkets.com/reports/c9310) has announced the addition of Winning Pharmaceutical R&D Strategies: Boosting profitability through improvements in portfolio management, licensing and clinical trials to their offering. [PRWEB Nov 17, 2004]

Research and Markets: How Feasible is Blockbuster Drug Development as a Foundation of Major Pharma Growth?
Research and Markets (researchandmarkets.com/reports/c9320) has announced the addition of Future Growth Strategies: Drivers of sustainable development within the biotech, specialty and major pharma sectors to their offering. [PRWEB Nov 17, 2004]

Research and Markets - Increased Need to Maximise Impact of Pharma-Patient Group Alliances Across Range of Pharma Activities
Research and Markets (researchandmarkets.com/reports/c9324) has announced the addition of Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share to their offering. [PRWEB Nov 17, 2004]

Research and Markets - Succesful Strategies behind Innovative Cancer Therapies in the Marketplace Examined
Research and Markets (researchandmarkets.com/reports/c9330) has announced the addition of Targeted Cancer Therapies: Innovative drugs and their impact on the future of oncology to their offering. [PRWEB Nov 17, 2004]

An Alternative for "Alternative Medicine"? How atomic physics can revolutionize the supplement industry.
Progess in our understanding of the health benefits of nutritional and botanical supplements has been slow. Today, Vitalea Science, debuts technological platform that can answer many of the lingering questions concerning the role of these products in human health and disease. The technology, Accelerator Mass Spectrometry, was developed for atomic physics, but will now reinvigorate supplement research at a level of detail that was previously only available to the pharmaceutical industry. [PRWEB Nov 16, 2004]

Research And Markets: Today, The Necessity To Have Mechanisms For Obtaining, Recording, Storing And Submitting Suspected Adverse Drug Reactions To The Regulatory Authorities Is Vital
[PRWEB Nov 16, 2004]

Research and Markets - How is ADME/Tox Data Being Employed in NCE Discovery
Research and Markets (researchandmarkets.com/reports/c9210) has announced the addition of A Survey of ADME-TOX Trends in Drug Development to their offering. [PRWEB Nov 16, 2004]

Company Offers Affordable Alternative to Expensive Health Insurance.
Company Offers Affordable Alternative to Expensive Health Insurance. [PRWEB Nov 15, 2004]

Why the Greatest Vitamin in the World As Seen on TV is Taking The World of Nutrition by Storm
Your Health is Your Greatest Asset. The Greatest Vitamin In the World Educates you on Nutrition for Your health and well being. Exciting News is here! [PRWEB Nov 15, 2004]

A New Revolution in Pulsation Dampening
Blacoh’s “Revolution” Pulsation Dampener was the first of its kind to feature threaded housings instead of metal fasteners, making it nearly impervious to the damaging effects of corrosive environments. Now, the innovation continues as standard PVC construction has been upgraded to CPVC. The benefits of this upgrade are significant. [PRWEB Nov 15, 2004]

Research and Markets - Current uses of Green-Fluorescent Protein in Biopharmaceutical Industry Examined
Research and Markets (researchandmarkets.com/reports/c9202) has announced the addition of A Guide to Green-Fluorescent Protein to their offering. [PRWEB Nov 15, 2004]

Research and Markets - Analysis of Drug Development Life Cycle enabling Organisations to remain Competitive in Today's Evolving Marketplace
Research and Markets (researchandmarkets.com/reports/c9224) has announced the addition of Drug and Market Development Journal to their offering. [PRWEB Nov 15, 2004]

Research and Markets - Commercial Viability of Phosphatase Enzyme Class as Therapeutic Targets Analysed
Research and Markets (researchandmarkets.com/reports/c9232) has announced the addition of Phosphatases: Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets to their offering. [PRWEB Nov 15, 2004]

Piribo - Development of COX-2 Inhibitors Continues
Learning from the fallout from Vioxx’s withdrawal. [PRWEB Nov 15, 2004]

Eve's Herbs: Therapy Packs, Herbal Remedies & Nutrition
Dr Eve Campanelli (Ph.D) features herbal remedies and special herb and homeopathic therapy packs on her new website at www.evesherbs.com [PRWEB Nov 14, 2004]

Weaver Law Group - Chicago, IL
Weaver Law Group, a Chicago based regulatory law firm, today unveiled its new client-focused web site. This site was designed to deliver vital information to visitors and clients, providing an improved interface and easy-to-use navigational tools. [PRWEB Nov 12, 2004]

OMNI Awarded Large Contract to Design & Build the USP Pure Water Systems for a Major Pharmaceutical Company
OMNI Technologies, Inc. (OTI) An established supplier of Engineered Systems, Automation/Process Technology, Skid/Cart Fabrication and Instrumentation Services, today announced that it has been awarded a second phase for the complete Design and Build of the USP Pure Water Final Rinse Systems for this Pharmaceutical company; bringing the total project to over $2.2 million in revenues for OMNI Technologies, Inc. [PRWEB Nov 12, 2004]

Two Important New Healthcare Training Sites Launched by IntraLearn Partner - Train for Patient Safety and Train for Pharma sites extend Train for Compliance offerings
- IntraLearn Software Corporation, the leading supplier of turnkey e-Learning software applications, announced today that partner Train for Compliance has launched two important new healthcare compliance and practice training websites: Train for Patient Safety and Train for Pharma. Train for Compliance now offers approximately 100 healthcare compliance and practice courses through its affiliated websites. Train for Compliance uses the IntraLearn LSP e-Learning platform for delivery for all of its online courses. [PRWEB Nov 11, 2004]

Pharmachem Joins Philanthropic Program to Help Malnourished Children
Pharmachem Laboratories Inc. announces its collaboration with Vitamin Angel Alliance, a charitable organization, to provide multi-vitamins for impoverished and malnourished children in Tibet. Together with Pharmachem and other partners, the Alliance recently sent more than 645,000 multi-vitamin tablets to Tibet, and will continue to ship this same quantity on a monthly basis. [PRWEB Nov 10, 2004]

Research And Markets - View The Most Up To Date Analysis Of OTC Distribution In Europe
Research and Markets (researchandmarkets.com/reports/c8787) has announced the addition of OTC Distribution in Europe - the New 2005 Edition to their offering. [PRWEB Nov 10, 2004]

Post-Genomic Biomarker-Based Diagnostic Products are Projected To Grow From $100 Million in 2003 to $2 Billion by 2008
Research and Markets (researchandmarkets.com/reports/c8902) has announced the addition of Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics to their offering. [PRWEB Nov 10, 2004]

© PR Web: Medical Pharmaceuticals